Eupraxia Pharmaceuticals Inc. (EPRX) stock
EPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.21−0.41 (-6.19%)
Close on Nov 18, 2026Market cap $374.43MP/E –Yield –
Eupraxia Pharmaceuticals net income
Net income is the profit left for shareholders after every expense, interest and tax.
For fiscal 2025 it was -$38.58M.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$38.58M | – |
| FY2024 | Dec 31, 2024 | -$25.50M | – |
| FY2023 | Dec 31, 2023 | -$28.22M | – |
| FY2022 | Dec 31, 2022 | -$18.49M | – |
See a number that looks wrong?